- Fan L, Du P, Li Y, Chen X, Liu F, Liu Y, Petrov AM, Li X*, Wang Z*, Zhao Y*, 2024. Targeted liposomes sensitize plastic melanoma to ferroptosis via senescence induction and coenzyme depletion. ACS Nano, 18(9): 7011-7023.
- Song Y, Xu X, Wang Z*, Zhao Y*, 2024. Metal-organic framework-based nanomedicines for ferroptotic cancer therapy. Adv Healthc Mater, 13(11): e2303533.
- Gao Z, Zhang J, Hou Y, Lu J, Liang J, Gao Y, Li B, Gao S, Zhao Y*, Gao M*, Chen J*, 2024. Boosting the synergism between cancer ferroptosis and immunotherapy via targeted stimuli-responsive liposomes. Biomaterials, 305: 122442.
- Luo J, Li Y, Li Y, Chen X, Du P, Wang Z, Tian A,* Zhao Y*, 2023. Reversing ferroptosis resistance in breast cancer via tailored lipid and iron presentation. ACS Nano, 17(24): 25257-25268.
- Li Y, Wang J, Li Y, Luo J, Liu F, Chen T, Ji Y, Yang H, Wang Z, Zhao Y*, 2023. Attenuating uncontrolled inflammation by radical trapping chiral polymer micelles. ACS Nano, 17(13): 12127-12139.
- Meng X*, Wang L, Zhao N, Zhao D, Shen Y, Yao Y, Jing W, Man S, Dai Y*, Zhao Y*, 2023. Stimuli-responsive cancer nanomedicines inhibit glycolysis and impair redox homeostasis. Acta Biomater, 167: 374-386.
- Chen T, Qin Y, Li Y, Li Y, Luo J, Fan L, Feng M, Wang Z, Zhao Y*, 2023. Chiral polymer micelles alleviate adriamycin cardiotoxicity via iron chelation and ferroptosis inhibition. Adv Func Mater, 33(30): 2300689.
- Li Y, Feng M, Guo T, Wang Z, Zhao Y*, 2023. Tailored beta-lapachone nanomedicines for cancer-specific therapy. Adv Healthc Mater, 12(20): 2300349.
- Li Y, Liu M, Zheng Y, Wang Z*, Zhao Y*, 2023. Coenzyme-depleting nanocarriers for enhanced redox cancer therapy under hypoxia. J Colloid Interface Sci, 641: 135-145.
- Wang Z, Mu X, Yang Q, Luo J, Zhao Y*, 2022. Hypoxia-responsive nanocarriers for chemotherapy sensitization via dual-mode inhibition of hypoxia-inducible factor-1 alpha. J Colloid Interface Sci, 628: 106-115.